Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation (Nabi-HB-SC)
This study has been withdrawn prior to enrollment.
(New sponsor's existing product under evaluation for this indication)
Sponsor:
Biotest Pharmaceuticals Corporation
Information provided by:
Biotest Pharmaceuticals Corporation
ClinicalTrials.gov Identifier:
NCT00800787
First received: November 26, 2008
Last updated: June 29, 2010
Last verified: June 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Study Status: | This study has been withdrawn prior to enrollment. |
|---|---|
| Estimated Study Completion Date: | September 2010 |
| Estimated Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |